Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors

Rigshospitalet, University Hospital of Copenhagen, Copenhagen

Peter MacCallum Cancer Centre, Melbourne

Westchester Medical Center, Hawthorne

Seoul National University Bundang Hosptial, Seongnam-si

The Catholic University of Korea St. Vincent Hosptial, Suwon

Thomas Jefferson University Hospital, Philadelphia

IRCCS Ospedale San Raffaele, Milan

Fondazione IRCCS Istituto Nazionale Tumori, Milan

IRCCS (IEO) Istituto Europeo di Oncologia, Milan

Hospital Universitario Ramon y Cajal, Madrid

Hospital Universitario La Paz, Madrid

Florida Cancer Specialists, Lake Mary

Institut Bergonie, Bordeaux

Sylvester Comprehensive Cancer Center (University of Miami), Miami

Miami Cancer Institute, Miami

Azienda Ospedaliera Universitaria Integrata Verona, Verona

Tennessee Oncology, PLLC, Nashville

Marienhospital Herne, Herne

Azienda Ospedaliero Universitaria delle Marche, Ancona

Dr. Senckenberg Institute of Neurooncology, Frankfurt am Main

Centre Léon Bérard, Lyon

Universitaetsklinikum Heidelberg, Heidelberg

Hopital Europeen Georges Pompidou, Paris

The University of Texas MD Anderson Cancer Center, Houston

IRCCS Istituto Nazionale Tumori Fondazione Pascale, Napoli

Sarah Cannon Research Institute at HealthONE, Denver

CHU Poitiers - Hopital la Miletrie, Poitiers

John Wayne Cancer Institute at St. Johns Health Center, Santa Monica

Stanford Hospital and Clinics, Stanford

Institut Gustave Roussy, Villejuif

National Cancer Centre Singapore, Singapore

Dana-Farber Cancer Institute, Boston

Queen Mary Hospital, Pok Fu Lam

Prince of Wales Hospital, Shatin

Severance Hosptial, Yonsei University Health System, Seoul

Samsung Medical Center, Seoul

The Catholic University of Korea Soul St. Mary's Hosptial, Seoul

Hospital Universitari Vall d Hebron, Barcelona

ICO l Hospitalet, L'Hospitalet de Llobregat

Hospital General de Catalunya, Sant Cugat del Vallès

The Christie, Manchester

Royal Marsden Hospital Institute Cancer Research, Sutton